BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 29113975)

  • 1. G-quadruplex-binding small molecules ameliorate
    Simone R; Balendra R; Moens TG; Preza E; Wilson KM; Heslegrave A; Woodling NS; Niccoli T; Gilbert-Jaramillo J; Abdelkarim S; Clayton EL; Clarke M; Konrad MT; Nicoll AJ; Mitchell JS; Calvo A; Chio A; Houlden H; Polke JM; Ismail MA; Stephens CE; Vo T; Farahat AA; Wilson WD; Boykin DW; Zetterberg H; Partridge L; Wray S; Parkinson G; Neidle S; Patani R; Fratta P; Isaacs AM
    EMBO Mol Med; 2018 Jan; 10(1):22-31. PubMed ID: 29113975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins.
    Zamiri B; Reddy K; Macgregor RB; Pearson CE
    J Biol Chem; 2014 Feb; 289(8):4653-9. PubMed ID: 24371143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures.
    Reddy K; Zamiri B; Stanley SYR; Macgregor RB; Pearson CE
    J Biol Chem; 2013 Apr; 288(14):9860-9866. PubMed ID: 23423380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes.
    Fratta P; Mizielinska S; Nicoll AJ; Zloh M; Fisher EM; Parkinson G; Isaacs AM
    Sci Rep; 2012; 2():1016. PubMed ID: 23264878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in
    Fujino Y; Ueyama M; Ishiguro T; Ozawa D; Ito H; Sugiki T; Murata A; Ishiguro A; Gendron T; Mori K; Tokuda E; Taminato T; Konno T; Koyama A; Kawabe Y; Takeuchi T; Furukawa Y; Fujiwara T; Ikeda M; Mizuno T; Mochizuki H; Mizusawa H; Wada K; Ishikawa K; Onodera O; Nakatani K; Petrucelli L; Taguchi H; Nagai Y
    Elife; 2023 Jul; 12():. PubMed ID: 37461319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insight into C9orf72 hexanucleotide repeat expansions: Towards new therapeutic targets in FTD-ALS.
    Kumar V; Kashav T; Islam A; Ahmad F; Hassan MI
    Neurochem Int; 2016 Nov; 100():11-20. PubMed ID: 27539655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic reduction of GGGGCC repeat RNA levels by hnRNPA3 suppresses neurodegeneration in Drosophila models of C9orf72-linked ALS/FTD.
    Taminato T; Takeuchi T; Ueyama M; Mori K; Ikeda M; Mochizuki H; Nagai Y
    Hum Mol Genet; 2023 May; 32(10):1673-1682. PubMed ID: 36611007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ALS/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexes.
    Raguseo F; Wang Y; Li J; Petrić Howe M; Balendra R; Huyghebaert A; Vadukul DM; Tanase DA; Maher TE; Malouf L; Rubio-Sánchez R; Aprile FA; Elani Y; Patani R; Di Michele L; Di Antonio M
    Nat Commun; 2023 Dec; 14(1):8272. PubMed ID: 38092738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of parallel G-quadruplex formed by the two-repeat ALS- and FTD-related GGGGCC sequence.
    Geng Y; Liu C; Cai Q; Luo Z; Miao H; Shi X; Xu N; Fung CP; Choy TT; Yan B; Li N; Qian P; Zhou B; Zhu G
    Nucleic Acids Res; 2021 Jun; 49(10):5881-5890. PubMed ID: 34048588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons.
    Almeida S; Gascon E; Tran H; Chou HJ; Gendron TF; Degroot S; Tapper AR; Sellier C; Charlet-Berguerand N; Karydas A; Seeley WW; Boxer AL; Petrucelli L; Miller BL; Gao FB
    Acta Neuropathol; 2013 Sep; 126(3):385-99. PubMed ID: 23836290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD.
    Ursu A; Wang KW; Bush JA; Choudhary S; Chen JL; Baisden JT; Zhang YJ; Gendron TF; Petrucelli L; Yildirim I; Disney MD
    ACS Chem Biol; 2020 Dec; 15(12):3112-3123. PubMed ID: 33196168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3.
    Ramesh N; Daley EL; Gleixner AM; Mann JR; Kour S; Mawrie D; Anderson EN; Kofler J; Donnelly CJ; Kiskinis E; Pandey UB
    Acta Neuropathol Commun; 2020 Oct; 8(1):177. PubMed ID: 33129345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All in the Family: Repeats and ALS/FTD.
    Pattamatta A; Cleary JD; Ranum LPW
    Trends Neurosci; 2018 May; 41(5):247-250. PubMed ID: 29703376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective
    Cheng A; Liu C; Ye W; Huang D; She W; Liu X; Fung CP; Xu N; Suen MC; Ye W; Sung HHY; Williams ID; Zhu G; Qian PY
    J Med Chem; 2022 Oct; 65(19):12825-12837. PubMed ID: 36226410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs.
    Jiang J; Zhu Q; Gendron TF; Saberi S; McAlonis-Downes M; Seelman A; Stauffer JE; Jafar-Nejad P; Drenner K; Schulte D; Chun S; Sun S; Ling SC; Myers B; Engelhardt J; Katz M; Baughn M; Platoshyn O; Marsala M; Watt A; Heyser CJ; Ard MC; De Muynck L; Daughrity LM; Swing DA; Tessarollo L; Jung CJ; Delpoux A; Utzschneider DT; Hedrick SM; de Jong PJ; Edbauer D; Van Damme P; Petrucelli L; Shaw CE; Bennett CF; Da Cruz S; Ravits J; Rigo F; Cleveland DW; Lagier-Tourenne C
    Neuron; 2016 May; 90(3):535-50. PubMed ID: 27112497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-Quadruplexes Formation by the
    Zhang Y; Huang J; Yu K; Cui X
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.
    Donnelly CJ; Zhang PW; Pham JT; Haeusler AR; Mistry NA; Vidensky S; Daley EL; Poth EM; Hoover B; Fines DM; Maragakis N; Tienari PJ; Petrucelli L; Traynor BJ; Wang J; Rigo F; Bennett CF; Blackshaw S; Sattler R; Rothstein JD
    Neuron; 2013 Oct; 80(2):415-28. PubMed ID: 24139042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription elongation factor AFF2/FMR2 regulates expression of expanded GGGGCC repeat-containing C9ORF72 allele in ALS/FTD.
    Yuva-Aydemir Y; Almeida S; Krishnan G; Gendron TF; Gao FB
    Nat Commun; 2019 Nov; 10(1):5466. PubMed ID: 31784536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia.
    Brown DG; Shorter J; Wobst HJ
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126942. PubMed ID: 31926785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.